A Study to Evaluate Safety, Toleration and Time Course of Plasma Concentration of Multiple Oral Doses of PF-06273340 in Healthy Subjects of Two AgeGroups, Aged 18-55 Years (Group 1) and Aged 56-75 Years (Group 2)
NCT01934738 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2014-03-11
Summary
The purpose of this study is to investigate safety, toleration and time course of plasma concentration of multiple oral doses of PF-06273340 for 14 days in healthy subjects of two age groups, aged 18-55 years (Group 1) and aged 56-75 years (Group 2)
Conditions
- Healthy
Interventions
- DRUG
-
PF-06273340
Tablets, 100 mg TID, 14 days
- DRUG
-
Tablets, TID, 14 days
- DRUG
-
PF-06273340
Tablets, to be decided dose, TID or titration, 14 days
- DRUG
-
Tablets, TID or titration, 14 days
- DRUG
-
PF-06273340
Tablets, to be decided dose, TID or titration, 14 days
- DRUG
-
Tablets, TID or titration, 14 days
- DRUG
-
PF-06273340
Tablets, to be decided dose, TID or titration, 14 days
- DRUG
-
Tablets, TID or titration, 14 days
- DRUG
-
PF-06273340
Tablets, to be decided dose, TID or titration, 14 days
- DRUG
-
Tablets, TID or titration, 14 days
- DRUG
-
PF-06273340
Tablets, to be decided dose, TID or titration, 14 days
- DRUG
-
Tablets, TID or titration, 14 days
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-10-31
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- Belgium
Study Locations
More Related Trials
-
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
NCT02151617 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults
NCT06659250 ·Status: COMPLETED ·Phase: PHASE1
-
A Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentration Of Multiple Oral Doses Of PF-04895162
NCT01691274 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of Oral Pf-06650833 In Healthy Subjects
NCT02485769 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants
NCT04323124 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects
NCT03217604 ·Status: COMPLETED ·Phase: PHASE1
-
Study in Healthy Subjects to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06687234
NCT02711462 ·Status: TERMINATED ·Phase: PHASE1
-
A Single Dose Study Of PF-06291874 In Healthy Adult Subjects
NCT01499017 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859
NCT02766621 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the Body in Healthy Adults.
NCT06532383 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults
NCT01753791 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability And Pharmacokinetics Of PF-06282999 Administered Orally In Healthy Adult Subjects
NCT01626976 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Observe Safety And Blood Concentrations Of PF-06412562 During And Following The Oral Administration Of Multiple Doses Of PF-06412562 In Healthy Adult Volunteers
NCT01959594 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Repeat Doses of PF-06372865 in Healthy Subjects
NCT03351751 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State
NCT01706796 ·Status: COMPLETED ·Phase: PHASE1
-
Group Study To Investigate The Safety, Toleration And Pharmacokinetics Of Multiple Oral Doses Of PF-04531083 In Healthy Subjects
NCT01012310 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults
NCT06137729 ·Status: TERMINATED ·Phase: PHASE1
-
A Study In Healthy People To Investigate The Safety, Toleration And Time Course Of Blood Concentrations Of Multiple Doses Of PF-03654764, Given By Mouth
NCT00989391 ·Status: COMPLETED ·Phase: PHASE1
-
Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects
NCT02871037 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability Study of Multiple Doses of PF-06305591
NCT01776619 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-05230907 In Healthy Volunteers
NCT01897142 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects
NCT03230383 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512
NCT03146065 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Multiple Oral Doses of PF-06835919 in Healthy Adult Japanese Participants
NCT04427917 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants
NCT04124653 ·Status: COMPLETED ·Phase: PHASE1